Lunai Bioworks (LNAI) Change in Account Payables (2011 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Change in Account Payables of $639638.0 in Q1 2026, up 160.87% quarter-over-quarter from $245191.0 in Q4 2025, and down 19.19% on a YoY basis from $791503.0 in Q1 2025.
Lunai Bioworks (LNAI) Change in Account Payables (2011 - 2026) Analysis & Trends
Lunai Bioworks' Change in Account Payables history runs 15 years deep, the most recent figure standing at $639638.0 for Q1 2026.
- In Q1 2026, Change in Account Payables fell 19.19% year-over-year to $639638.0; the TTM figure through Mar 2026 stood at $2.2 million (down 46.84% YoY), while the FY2025 annual figure was $3.1 million, down 23.44% from the prior year.
- Change in Account Payables was $639638.0 for Q1 2026 at Lunai Bioworks, up from $245191.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $3.3 million in Q3 2022 to a low of -$467667.0 in Q4 2024.
- Historically, Change in Account Payables has averaged $806504.2 across 5 years, with a median of $639638.0 in 2026.
- Biggest YoY gain for Change in Account Payables was 2280.89% in 2024; the steepest drop was 398.27% in 2024.
- A 5-year view of Change in Account Payables shows it stood at -$127519.0 in 2022, then jumped by 222.96% to $156792.0 in 2023, then plunged by 398.27% to -$467667.0 in 2024, then surged by 152.43% to $245191.0 in 2025, then jumped by 160.87% to $639638.0 in 2026.
- The last three Change in Account Payables figures came in at $639638.0 (Q1 2026), $245191.0 (Q4 2025), and $532206.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | 639,638.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 639,638.00 |
| Mar 31, 2026 | 639,638.00 |
| Dec 31, 2025 | 245,191.00 |
| Dec 31, 2025 | 245,191.00 |
| Sep 30, 2025 | 532,206.00 |
| Sep 30, 2025 | 532,206.00 |
| Jun 30, 2025 | 828,806.00 |
| Jun 30, 2025 | 828,806.00 |
| Mar 31, 2025 | 791,503.00 |
| Mar 31, 2025 | 791,503.00 |
| Dec 31, 2024 | -467,667.00 |
| Dec 31, 2024 | -467,667.00 |
| Sep 30, 2024 | 1.95 Mn |
| Sep 30, 2024 | 1.95 Mn |
| Jun 30, 2024 | 1.95 Mn |
| Jun 30, 2024 | 1.95 Mn |
| Mar 31, 2024 | 1.83 Mn |
| Mar 31, 2024 | 1.83 Mn |
| Dec 31, 2023 | 156,792.00 |
| Dec 31, 2023 | 156,792.00 |